CALM2P4

Across TCGA pan-cancer cohorts, CALM2P4 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated CALM2P4 data layer.

The strongest signal is observed in thymoma (THYM), where higher CALM2P4 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated CALM2P4 expression acts as an unfavorable survival marker, although some lineages such as MESO and KIRP show a favorable association.

THYM, ACC, and ESCA are the cancer types where CALM2P4 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THYM	OS	Tertile	II,III,IV	0.761	0.978	.013	36	view →
ACC	DFS	Quartile	All	0.452	0.716	.003	33	view →
ESCA	DFS	Tertile	All	0.288	1.000	.004	12	view →
READ	OS	Tertile	IV	0.371	0.814	.002	10	view →
MESO	DFS	Tertile	III,IV	0.508	0.332	.037	9	view →
KIRP	DFS	Tertile	III,IV	0.819	0.286	.034	8	view →
CHOL	DFS	Tertile	All	0.746	0.253	.042	6	view →
BRCA	OS	Quartile	All	0.495	0.564	.032	6	view →
LIHC	DFS	Tertile	All	0.322	0.456	.043	6	view →
PAAD	OS	Median	All	0.259	0.427	.021	5	view →
CESC	OS	Median	II,III,IV	0.850	0.678	.023	4	view →
THCA	OS	Median	All	0.975	0.916	.028	4	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

CALM2P4–THYM (OS)

Open the THYM breakdown →